Whalen Wealth Management Inc. Makes New $670,000 Investment in Oscar Health, Inc. (NYSE:OSCR)

Whalen Wealth Management Inc. acquired a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 49,823 shares of the company's stock, valued at approximately $670,000.

Other institutional investors have also modified their holdings of the company. State Street Corp raised its holdings in Oscar Health by 6.0% during the third quarter. State Street Corp now owns 5,132,802 shares of the company's stock worth $108,867,000 after purchasing an additional 291,335 shares in the last quarter. Geode Capital Management LLC raised its holdings in Oscar Health by 11.7% during the third quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company's stock valued at $92,062,000 after buying an additional 455,205 shares in the last quarter. Hennessy Advisors Inc. raised its position in shares of Oscar Health by 550.3% in the fourth quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company's stock valued at $56,292,000 after purchasing an additional 3,544,300 shares during the period. JPMorgan Chase & Co. increased its stake in shares of Oscar Health by 68.5% in the third quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company's stock worth $48,977,000 after purchasing an additional 938,742 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its position in Oscar Health by 20.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,600,166 shares of the company's stock worth $33,940,000 after acquiring an additional 270,223 shares during the period. Institutional investors and hedge funds own 75.70% of the company's stock.

Insider Activity

In other Oscar Health news, Vice Chairman Joshua Kushner purchased 276,040 shares of the business's stock in a transaction dated Monday, November 11th. The shares were bought at an average price of $13.58 per share, for a total transaction of $3,748,623.20. Following the completion of the acquisition, the insider now owns 5,031,262 shares in the company, valued at approximately $68,324,537.96. This trade represents a 5.80 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Victoria Baltrus sold 8,078 shares of the stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $146,050.24. Following the completion of the sale, the chief accounting officer now owns 146,036 shares of the company's stock, valued at $2,640,330.88. The trade was a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders bought 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. 25.11% of the stock is owned by corporate insiders.

Oscar Health Price Performance

OSCR traded up $0.18 during trading on Thursday, hitting $16.44. 2,579,371 shares of the stock traded hands, compared to its average volume of 3,111,531. The business has a 50 day moving average price of $15.17 and a 200 day moving average price of $16.81. The company has a market cap of $4.07 billion, a price-to-earnings ratio of -274.00, a PEG ratio of 0.63 and a beta of 1.70. Oscar Health, Inc. has a twelve month low of $11.38 and a twelve month high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). The company had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm's revenue was up 68.3% compared to the same quarter last year. During the same period last year, the company posted ($0.29) EPS. Equities research analysts forecast that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Jefferies Financial Group started coverage on Oscar Health in a report on Tuesday, December 10th. They issued an "underperform" rating and a $12.00 price target for the company. UBS Group initiated coverage on Oscar Health in a report on Monday, October 7th. They set a "neutral" rating and a $23.00 price target for the company. Finally, Bank of America downgraded Oscar Health from a "neutral" rating to an "underperform" rating and decreased their target price for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. Two research analysts have rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $21.56.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.